Flagship explainer

How Insight Molecular Diagnostics Inc. makes its money

Start with a dollar of revenue and follow what the filing says remains.

revenueBranching filed flows with values and percentages directly labeled. Missing filing concepts are omitted rather than estimated.Revenue$4.1M · 100%Cost of revenue$1.8M · 43%Gross profit$2.3M · 57%Operating income−$51.1M · −1261%Income before tax−$50.2M · −1239%Income tax$0 · 0%Net income−$50.2M · −1239%As of 2025-12-31 · 1 SEC filing sourceBuy Like Buffett · buylikebuffett.com

Honest partial: the filing did not provide a normalized tag for Research and development, Selling, general and administrative; those components are omitted, not plugged.

Table alternative
Filed lineValue% of revenueSource
$4.1M100%
Cost of revenue$1.8M43%
$2.3M57%
−$51.1M−1261%
Income before tax−$50.2M−1239%
Income tax$00%
−$50.2M−1239%
Source: · event Dec 31, 2025 · retrieved Oct 16, 2026 · annual-row source set
Embed this chart

View the full Insight Molecular Diagnostics Inc. analysis at Buy Like Buffett